Literature DB >> 11589913

Genetic risk factors in familial Alzheimer's disease.

S Sorbi1, P Forleo, A Tedde, E Cellini, M Ciantelli, S Bagnoli, B Nacmias.   

Abstract

In the last 10 years significant progress has been made to describe and identify the underlying biological mechanisms that cause the different manifestation of Alzheimer's disease. Since the first report of a possible locus on chromosome 21 in a small group of families with early onset familial Alzheimer's disease (FAD), considerable progress has been made. Results from linkage analysis and gene sequencing has provided evidence that a minority of early onset FAD families develops the disease as a result of mutations in the gene coding for the Abeta-amyloid precursor protein, and that mutations in presenilin 1 and 2 genes account for a larger subgroup of early onset families. Several other early onset FAD families are clearly not linked to any of these loci, suggesting that other genetic risk factors may exist. Recent genome-wide scanning studies have revealed the existence of a new locus on chromosome 12, which, together with inheritance of the epsilon4 allele of apolipoprotein E gene, on chromosome 19, represent the most important genetic factors associated with an increased risk of developing the disease in late onset FAD families.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589913     DOI: 10.1016/s0047-6374(01)00308-6

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  6 in total

Review 1.  Evidence for defective retinoid transport and function in late onset Alzheimer's disease.

Authors:  Ann B Goodman; Arthur B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 2.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

3.  Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer's Disease Using Bioinformatics Analysis.

Authors:  Wuhan Yu; Weihua Yu; Yan Yang; Yang Lü
Journal:  Front Aging Neurosci       Date:  2021-06-14       Impact factor: 5.750

Review 4.  Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

Authors:  Benoît Leclerc; Abedelnasser Abulrob
Journal:  ScientificWorldJournal       Date:  2013-02-05

Review 5.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

6.  A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.

Authors:  Ebru Ercan-Herbst; Jens Ehrig; David C Schöndorf; Annika Behrendt; Bernd Klaus; Borja Gomez Ramos; Nuria Prat Oriol; Christian Weber; Dagmar E Ehrnhoefer
Journal:  Acta Neuropathol Commun       Date:  2019-12-03       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.